Royal London Asset Management
ABMD

Royal London Asset Management’s Abiomed Inc ABMD Stock Holding History

Royal London Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,950
Closed -$3.68M – 683
2022
Q3 		$3.68M Sell
14,950
-1,110
-7% -$300K 0.02% 509
2022
Q2 		$3.98M Hold
16,060
– – 0.02% 512
2022
Q1 		$5.32M Buy
16,060
+304
+2% +$93.6K 0.02% 482
2021
Q4 		$5.66M Sell
15,756
-575
-4% -$194K 0.02% 466
2021
Q3 		$5.32M Buy
16,331
+432
+3% +$146K 0.02% 479
2021
Q2 		$4.96M Hold
15,899
– – 0.02% 516
2021
Q1 		$5.07M Buy
15,899
+487
+3% +$156K 0.02% 490
2020
Q4 		$5M Sell
15,412
-806
-5% -$223K 0.03% 450
2020
Q3 		$4.42M Sell
16,218
-32
-0.2% -$9.22K 0.03% 430
2020
Q2 		$3.9M Sell
16,250
-696
-4% -$140K 0.03% 439
2020
Q1 		$2.52M Hold
16,946
– – 0.02% 500
2019
Q4 		$2.83M Hold
16,946
– – 0.02% 540
2019
Q3 		$3.02M Buy
+16,946
New +$3.66M 0.02% 528
2019
Q2 		– Sell
-17,468
Closed -$4.99M – 648
2019
Q1 		$4.99M Hold
17,468
– – 0.04% 434
2018
Q4 		$5.56M Buy
17,468
+1,346
+8% +$468K 0.05% 368
2018
Q3 		$7.25M Buy
+16,122
New +$6.36M 0.07% 264

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal London Asset Management's ABMD Position: Q4 2022 in Review

Royal London Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 14,950 shares — an estimated $3.68M sold.

Royal London Asset Management first reported a position in ABMD in Q3 2018 and held it in 16 quarters. The position peaked at $7.25M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Royal London Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Royal London Asset Management sold 14,950 Abiomed Inc shares in Q4 2022, an estimated $3.68M.
  • Royal London Asset Management first reported a position in Abiomed Inc in Q3 2018 and held it in 16 quarters.
  • Royal London Asset Management's Abiomed Inc position peaked at $7.25M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Royal London Asset Management's 13F filing for Q4 2022, filed 9 Feb 2023.